ÂÜÀòÂÒÂ×

Samantha Gao-Sheridan is an accomplished regulatory affairs leader with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Vice President and Head of Global Regulatory Affairs CMC at PTC Therapeutics, Inc., Samantha has been instrumental in developing and establishing robust global regulatory strategies. Previous roles include Senior Director of Regulatory Affairs CMC at Alnylam Pharmaceuticals, Global Regulatory Lead for Rare Diseases at Shire Pharmaceuticals, and Director of Global Regulatory Affairs CMC at Shire Human Genetic Therapies. Samantha's career began with a focus on regulatory affairs at Wyeth Biotech and Vical Inc., where expertise was gained in managing submissions and regulatory strategies for various biologic products. Educational achievements include a PhD in Biochemistry and Molecular Biology from UC Irvine, a Postdoctoral Fellowship at Harvard Medical School, and a Master's degree in Toxicology from Rutgers University.